Navigation Links
Moms Prefer Natural, Safe Cough Syrup Choice
Date:9/17/2010

NEWTOWN SQUARE, Pa., Sept. 17 /PRNewswire/ -- Launching now in national pharmacy chains is Chestal®, a natural cough syrup free of dextromethorphan from Boiron, the world leader in homeopathic medicines. This introduction comes on the heels of the success of Chestal's counterpart, Children's Chestal®, which was launched two years ago amid concerns over the safety of other active cough syrup ingredients for small children. Boiron, with a 78-year history of reliability, reports sales of Children's Chestal increased by 304 percent(1) during the peak of last winter's cough season.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100917/PH67202)

(Logo: http://photos.prnewswire.com/prnh/20100917/PH67202)

"Parents need to know they have other choices available to them on store shelves that don't involve weighing the product's benefits against its risks," says Woodson Merrell, MD, chairman of the Department of Integrative Medicine at Beth Israel Medical Center, Manhattan. His statement refers to the U.S. Food and Drug Administration's estimation that 125 cough and cold products use dextromethorphan, an antitussive (cough suppressant drug) debated for its abuse by teens.

Named by New York magazine as a "Leader for the New Millennium," Dr. Merrell explains, "A homeopathic cough syrup like Children's Chestal works differently. Instead of working against the body as a suppressant, it works naturally with the body as an expectorant; therefore it is able to improve the productivity of a multitude of coughs."

First, the natural goodness of honey in Chestal coats and soothes the throat. The blend of safe homeopathic medicines then set to work loosening chest congestion to improve both dry and productive coughs for a speedier recovery. This combination provides non-drowsy relief that's important for busy folks throughout the day and a soothing effect that is appreciated at bedtime. Neither Chestal nor Children's Chestal carry a risk of abuse, drug interaction or overdose, and both are safe for everyone in the household ages 2 to 102.

Available either in the adult cough and cold section as Chestal or in the children's aisle as Children's Chestal, average retail price for the 8.45 fl. oz. family-size bottle is $10.99 and $6.80 for the smaller 4.2 fl. oz. bottle.

Chestal has been on the U.S. market in natural product stores since 1991 and longer in France, home of its manufacturer. Now parents can easily pick up Chestal for themselves or Children's Chestal on shelves nationwide at CVS, Rite Aid, Vitamin Shoppe, Walgreens and Whole Foods Markets, or at their local natural product store and independent pharmacy.

For more information on Children's Chestal, visit www.childrenschestal.com, call the Boiron Information Center at 1-800-BOIRON-1 (1-800-264-7661) or e-mail info@boironusa.com.

About Boiron: Boiron, world leader in homeopathy, is a $730 million public company with 4,000 employees and distribution in more than 80 countries. It is best known for its top-selling flu medicine, Oscillococcinum®, and its Arnicare® line of pain relievers. For nearly 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.

References

(1) IRI, for the total U.S. Drug, Children's Cough Syrup category for the 24-week period ending Feb. 21, 2010. (During the same time period, Children's Chestal was ranked the bestselling children's natural cough syrup and eighth among all children's cough syrup.)


'/>"/>
SOURCE Boiron USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nationwide Survey Shows Infertility Patients Prefer ENDOMETRIN(R) Compared With Other Progesterone Supplements
2. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
3. Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections
4. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
5. Mylan Declares Quarterly Preferred Stock Dividend
6. Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study
7. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
8. New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations
9. GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference
10. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
11. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... -- Consumer reviews on the independent review site Consumer Affairs ... for hearing aids, ranking it higher than Miracle Ear ™, ... ... Hearing Aids ... store that provides high performance, state-of-the-art, German-engineered hearing aids directly to ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):